TARGETING BCMA ACHIEVES DEEP AND DURABLE RESPONSES IN MULTIPLE MYELOMA

被引:0
|
作者
不详
机构
关键词
D O I
10.1158/2159-8290.CD-RW2018-203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Targeting BCMA with the antibody-drug conjugate GSK2857916 is well tolerated in a phase I trial. ©2019 American Association for Cancer Research.
引用
收藏
页码:12 / 12
页数:1
相关论文
共 50 条
  • [1] Targeting BCMA in Multiple Myeloma
    Tan, Carlyn Rose
    Shah, Urvi A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (05) : 367 - 383
  • [2] Targeting BCMA in Multiple Myeloma
    Carlyn Rose Tan
    Urvi A. Shah
    Current Hematologic Malignancy Reports, 2021, 16 : 367 - 383
  • [3] Antibody-based targeting of BCMA in multiple myeloma
    Morgan, Gareth J.
    Williams, Louis
    LANCET ONCOLOGY, 2020, 21 (02): : 186 - 187
  • [4] BCMA-targeting agents for refractory multiple myeloma
    van de Wyngaert, Zoe
    HEMATOLOGIE, 2023, 29 (02): : 107 - 120
  • [5] BCMA-targeting approaches for treatment of multiple myeloma
    Chen, Yunxin
    Nagarajan, Chandramouli
    Tan, Melinda S.
    Martinelli, Giovanni
    Cerchione, Claudio
    PANMINERVA MEDICA, 2021, 63 (01) : 28 - 36
  • [6] Targeting BCMA in multiple myeloma: designs, challenges, and future directions
    Yi Hu
    Yuetao Xie
    Xiaodong Wang
    Lufeng Yang
    He Geng
    Zugang Yi
    Yao Zhang
    Lin Ma
    Fang Chen
    Cancer Immunology, Immunotherapy, 74 (3)
  • [7] Proteasomal inhibition stabilizes BCMA and enhances efficacy of BCMA-targeting therapies in multiple myeloma
    Rieger, L.
    Irlinger, K.
    Fuchsl, F.
    Barbian, N.
    Faber, M.
    Schulze, T.
    Tietje, M.
    Schmidts, A.
    Giansanti, P.
    Besse, L.
    Driessen, C.
    Kuster, B.
    Krackhardt, A.
    Bassermann, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 234 - 234
  • [8] Designing APRIL-Based Therapeutics for Targeting BCMA in Multiple Myeloma
    Lee, Lydia S. H.
    Chaplin, Neil
    Draper, Benjamin
    Yong, Kwee
    Pule, Martin
    MOLECULAR THERAPY, 2014, 22 : S104 - S104
  • [9] Regulation of BCMA By the Ubiquitin Proteasome System Enables Optimization of BCMA-Targeting Therapies in Multiple Myeloma
    Rieger, Leonie
    Irlinger, Kilian
    Fuechsl, Franziska
    Barbian, Nicolas
    Tietje, Marlene
    Faber, Melanie
    Schulze, Tobias
    Giansanti, Piero
    Besse, Lenka
    Driessen, Christoph
    Krackhardt, Angela
    Kuster, Bernhard
    Bassermann, Florian
    BLOOD, 2023, 142
  • [10] Pharmacodynamics of SEA-BCMA, a Nonfucosylated Antibody Targeting BCMA, in Patients with Relapsed/Refractory Multiple Myeloma
    Taft, David
    Henderson, Clark
    O'Day, Christine
    Yu, Changpu
    Li, Hong
    Ho, Phoenix
    Van Epps, Heather
    BLOOD, 2021, 138